InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Dasu Badri N, Directeur de l'Ingénierie. Director active across 1 companies, notably Acelrx Pharmaceuticals INC. Aggregated, 4 filings have been recorded. The latest transaction was disclosed on 3 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€2,0545,612 shares@ €0.366128.5% of flow
Common Stock
SEC:0001209191-22-016248:0·
097,500 shares0
Common Stock
SEC:0001209191-22-009349:0·
€2,5756,830 shares@ €0.3771100.0% of flow
Common Stock
SEC:0001209191-22-007634·
€2,5756,830 shares@ €0.377135.7% of flow
Common Stock
SEC:0001209191-22-007634:0·
4 of 4 declarations
About Dasu Badri N
Badri N. Dasu is the Chief Engineering Officer at AcelRx Pharmaceuticals Inc. He oversees engineering and product development initiatives within the company. With expertise in the pharmaceutical sector, he plays a key role in innovation and enhancing the solutions offered by the company.
